Nanozyme‐Engineered Probiotic Microneedle Patch for Chronic Diabetic Wound Therapy
Advanced Science · 2025-12 · 12 (45)
DOI: 10.1002/advs.202512127 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 17.09.2025. Verfasst von Xueyang Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Burns, Tongren Hospital of Wuhan University (Wuhan Third Hospital), School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071,…. Hauptthemen laut MEDLINE: Probiotics, Wound Healing. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Chronic diabetic wounds are notoriously difficult to heal due to persistent bacterial infection, oxidative stress, and tissue hypoxia. Here, a multifunctional probiotic microneedle (MN) patch embedding platinum nanozyme‐engineered Bacillus subtilis (Pt‐M@ B. sub ) within a dissolvable, biocompatible polymer matrix is presented for synergistic diabetic wound therapy. This biohybrid system alleviates reactive oxygen species (ROS), combats bacterial infection, relieves hypoxia, and exerts anti‐inflammatory effects. The platinum nanozyme modification protects the probiotics of B. subtilis by scavenging ROS and generating oxygen in situ, thereby enhancing probiotic survival and function under harsh wound conditions. Upon transdermal application, the MN patch (termed Pt‐M@ B. sub MN patch) enables efficient, minimally invasive delivery of the therapeutic nanozyme‐modified probiotics directly into the wound bed, where the functionalized living material significantly suppressed Staphylococcus aureus infection, reduced inflammation, promoted collagen deposition and angiogenesis, and accelerated wound closure. Biosafety assessments confirmed excellent biocompatibility and systemic safety of the probiotic MN patch. Moreover, the patch exhibited efficient skin penetration and drug delivery in human cadaver skin, indicating strong clinical translation potential. Overall, this work introduces a robust living‐materials‐based strategy that integrates microbial therapy with catalytic nanotechnology for effective management of chronic infected wounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Burns, Tongren Hospital of Wuhan University (Wuhan Third Hospital), School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, P. R. China.
- Taikang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430071, P. R. China.
- Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, 430071, P. R. China.
ORCID-Profile: Wei Li
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, X., Liu, S., Jing, S., Zhang, S., Jin, Y., Zhang, W., Ruan, Q., & Li, W. (2025). Nanozyme‐Engineered Probiotic Microneedle Patch for Chronic Diabetic Wound Therapy. Advanced Science, 12(45). https://doi.org/10.1002/advs.202512127
Vancouver
Wang X, Liu S, Jing S, Zhang S, Jin Y, Zhang W, et al. Nanozyme‐Engineered Probiotic Microneedle Patch for Chronic Diabetic Wound Therapy. Advanced Science. 2025;12(45). doi:10.1002/advs.202512127
BibTeX
@article{Wang2025,
author = {Wang, Xueyang and Liu, Shuhua and Jing, Shisuo and Zhang, Siyu and Jin, Yinli and Zhang, Wen and Ruan, Qiongfang and Li, Wei},
title = {Nanozyme‐Engineered Probiotic Microneedle Patch for Chronic Diabetic Wound Therapy},
journal = {Advanced Science},
year = {2025},
volume = {12},
number = {45},
doi = {10.1002/advs.202512127}
}
EUVIMED